Literature DB >> 2506221

Epidemic Pseudomonas aeruginosa serotype O16 bacteremia in hematology-oncology patients.

H Richet1, M C Escande, J P Marie, R Zittoun, P H Lagrange.   

Abstract

From 1 August 1978 through 31 December 1982, 98 hematology-oncology patients had positive cultures for Pseudomonas aeruginosa serotype O16; 22 of these patients developed bacteremia, and this bacteremia was associated with the occurrence of extensive perineal cellulitis in 10 patients (45.5%). Seventeen bacteremic patients died. The epidemic strain differed from other P. aeruginosa organisms isolated at the hospital by its resistance to all antibiotics available at that time (ticarcillin, piperacillin, azlocillin, tobramycin, ceftizoxime, ceftriaxone, moxalactam, ceftazidime, and fosfomycin). Univariate analysis showed the following factors to be significantly associated with P. aeruginosa O16 bacteremia: the severity of granulocytopenia at the time of the bacteremia, more days with fever, the administration of ticarcillin or an aminoglycoside, the receipt of a greater number of antimicrobial agents for a longer period of time before documentation of the bacteremia, and the occurrence of cellulitis. Logistic regression analysis showed that duration of fever, duration of bacteremia, and the number of antimicrobial agents administered before documentation of the bacteremia were the best predictors of P. aeruginosa O16 bacteremia. In a prospective study of the acquisition of P. aeruginosa by hematology-oncology patients, 1,149 specimens (throat and rectal swabs) from 270 patients and 201 specimens from their washbasin drains were collected. On only three occasions was the epidemic strain isolated from both the patient and his or her washbasin, but in each case the colonization of the patient preceded the isolation of the strain from the washbasin. The transmission of any P. aeruginosa organism from washbasin drain to patient could not be documented. Contact isolation precautions from the Centers for Disease Control were used for all hematology-oncology patients colonized or infected with P. aeruginosa after 7 January 1983. No case of P. aeruginosa O16 bacteremia has occurred at Hotel Dieu since July 1984.

Entities:  

Mesh:

Year:  1989        PMID: 2506221      PMCID: PMC267725          DOI: 10.1128/jcm.27.9.1992-1996.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Epidemilogy of Pseudomonas in a burn intensive care unit.

Authors:  B G MacMillar; P Edmonds; R P Hummel; M P Maley
Journal:  J Trauma       Date:  1973-07

2.  Outbreaks of Pseudomonas aeruginosa infection in a nursery.

Authors:  D C Shanson
Journal:  J Hosp Infect       Date:  1980-03       Impact factor: 3.926

3.  Aminoglycoside-resistant Pseudomonas aeruginosa urinary tract infection: study of an outbreak.

Authors:  P W Smith; P G Rusnak
Journal:  J Hosp Infect       Date:  1981-03       Impact factor: 3.926

4.  Epidemiology of Pseudomonas infections in a pediatric intensive care unit.

Authors:  C D Morehead; P W Houck
Journal:  Am J Dis Child       Date:  1972-10

5.  Colonization with gentamicin-resistant Pseudomonas aeruginosa, pyocine type 5, in a burn unit.

Authors:  J A Shulman; P M Terry; C E Hough
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  Pseudomonas sternotomy wound infection and sternal osteomyelitis. Complications after open heart surgery.

Authors:  H G Stiver; J Clark; J Kennedy; M Cohen
Journal:  JAMA       Date:  1979-03-09       Impact factor: 56.272

7.  Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed.

Authors:  B Olson; R A Weinstein; C Nathan; W Chamberlin; S A Kabins
Journal:  J Infect Dis       Date:  1984-12       Impact factor: 5.226

Review 8.  Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients.

Authors:  B E Kreger; D E Craven; P C Carling; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

9.  Pseudomonas bacteremia. Retrospective analysis of 410 episodes.

Authors:  G P Bodey; L Jadeja; L Elting
Journal:  Arch Intern Med       Date:  1985-09
  9 in total
  5 in total

1.  Three new major somatic antigens of Pseudomonas aeruginosa.

Authors:  P V Liu; S Wang
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

2.  Molecular epidemiological study of Pseudomonas aeruginosa isolates from patients with acute leukemia.

Authors:  W Kern; C Wolz; G Döring
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

3.  Outbreak of gut colonization by Pseudomonas aeruginosa in immunocompromised children undergoing total digestive decontamination: analysis by pulsed-field electrophoresis.

Authors:  J Boukadida; M de Montalembert; J L Gaillard; J Gobin; F Grimont; D Girault; M Véron; P Berche
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

4.  Survey of susceptibility to selected antibiotics of Pseudomonas aeruginosa strains isolated from patients with tumor disease and their relationship to serotype.

Authors:  B Zatkovic; J Trupl; V Majtán
Journal:  Folia Microbiol (Praha)       Date:  1993       Impact factor: 2.099

5.  Nosocomial outbreak of severe Pseudomonas aeruginosa infections in haematological patients.

Authors:  A Grigis; A Goglio; M Parea; F Gnecchi; B Minetti; T Barbui
Journal:  Eur J Epidemiol       Date:  1993-07       Impact factor: 8.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.